Challenging Conversations about Dementia

Release Date, Expiration Date

Release: May 30, 2017
Expiration: May 30, 2019

Chair

David B. Carr, M.D.
Washington University School of Medicine
Alan A. and Edith L. Wolff Professor of Geriatric Medicine
Professor of Medicine and Neurology
Clinical Director
Division of Geriatrics and Nutritional Science
Division of Neurorehabilitation
Medical Director
The Rehabilitation Institute of St. Louis (TRISL)
Parc Provence
St. Louis, MO

Faculty

Eric McDade, D.O.
Associate Professor
Dominantly Inherited Alzheimer Network Trials Unit
Washington University School of Medicine
Department of Neurology
St. Louis, MO

Lenise Cummings-Vaughn, M.D.
Assistant Professor
Division of Geriatrics and Nutritional Science
Washington University School of Medicine
Medical Director
Stay Healthy Clinic and Outpatient Program
Barnes-Jewish Hospital
Associate Medical Director
Parc Provence
St. Louis, MO

Sponsorship Jointly provided by the Alzheimer’s Association and the Academy for Continued Healthcare Learning
Funding Statement Funding for this activity is provided through a grant from the MetLife Foundation.
Other Earn complimentary CME credit.
Copyright Statement with Logo National Headquarters
Alzheimer's Association National Office, 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
Alzheimer's Association is a not-for-profit 501(c)(3) organization.
© 2017 Alzheimer’s Association®. All rights reserved.
Disclaimer

All materials are included with permission. The opinions expressed are those of the faculty and are not to be construed as those of the publisher.

This educational activity was planned and produced in accordance with the ACCME Accreditation Criteria, Policies, and Standards for Commercial Support. Recommendations involving clinical medicine in a continuing medical education (CME/CE) activity must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients. All scientific research referred to, reported, or used in CME/CE in support or justification of a patient care recommendation must conform to the generally accepted standards of experimental design, data collection, and analysis.

This CME/CE activity might describe the off-label, investigational, or experimental use of medications that may exceed their FDA- approved labeling. Physicians should consult the current manufacturers’ prescribing information for these products. ACHL requires the speaker to disclose that a product is not labeled for the use under discussion.

Target Audience / Intended Audience This activity is intended to meet the educational needs of primary care clinicians including internists, family physicians, nurse practitioners and physician assistants who are seeking additional education in the assessment, diagnosis and ongoing health care of patients with cognitive impairment and dementia.
Statement of Need / Activity Purpose

Alzheimer’s disease (AD) affects more than 5 million Americans and is the sixth-leading cause of death in the United States. Quality care for AD and other dementias starts with an early, documented diagnosis, including disclosure of the diagnosis. However, among individuals living with Alzheimer’s and other dementias, evidence indicates about half have not been diagnosed, and of those who have been diagnosed, less than half are aware of their diagnosis. The reasons for the state of under-diagnosis are complex, but lack of follow-through by both patient and clinician play a role.

This five-module curriculum will educate primary care clinicians and provide tools that will lead to a more timely diagnosis of their patients and help them and their caregivers throughout the disease progression.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Recognize the signs indicative of dementia and mild cognitive impairment versus normal aging.
  • Identify and explain the benefits of early detection and diagnosis of mild cognitive impairment and/or dementia. 
  • Discuss next steps in the diagnostic process with patients who fail a cognitive screen in a clinical setting and prompt them to complete the process.  
  • Evaluate the behavioral, safety and functional needs of patients with AD as part of the care planning process.
  • Assess AD patients’ fitness to drive.
Method of Participation

This curriculum will take approximately 75 minutes to complete. To receive maximum credit, participants are required to view all five modules and achieve a score of at least 66 percent on the post-test. Upon completion of the activity evaluation form, a certificate will be immediately available. There is no fee to participate in the activity or for the generation of the certificate.

For questions, contact Lauren Seemeyer at lseemeyer@alz.org.

Joint Providership Accreditation Statement This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Academy for Continued Healthcare Learning (ACHL) and the Alzheimer’s Association. ACHL is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation

The Academy for Continued Healthcare Learning designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Nurse practitioners and physician assistants may receive a maximum of 1.25 Category 1 credits for completing this activity.

Faculty Disclosures

ACHL requires that the faculty participating in a CME/CE activity disclose all affiliations or other financial relationships (1) with the manufacturers of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation and (2) with any commercial supporters of the activity. All conflicts of interest have been resolved prior to this CME/CE activity.

The following financial relationships have been provided:

Eric McDade, D.O.
Grants/Research Support: Eli Lilly and Company and Hoffman-La Roche, Inc.

David B. Carr, M.D.
Consulting:
Sunnybrook Research Institute

Lenise Cummings-Vaughn, M.D., has no relevant financial relationships to disclose.

Discussion of Off-Label, Investigational, or Experimental Drug/Device Use: None

Staff and Reviewer Disclosures ACHL, Alzheimer’s Association staff members and others involved with the planning, development and review of the content for this activity have no relevant affiliations or financial relationships to disclose. 
Agenda

Module 1: Counseling the Worried Well Patient: Review of Alzheimer’s Disease and Dementia Risk Factors

Module 2: Diagnosing the Cause of Dementia: Why Is This Important?

Module 3: The Road Ahead to a Differential Diagnosis: What Can the Patient Expect?

Module 4:Caring for a Patient Newly Diagnosed with Alzheimer’s Disease: What Needs to Be Addressed?

Module 5: Driving Retirement: Challenging Conversations in Community Mobility

Hardware and Software Requirements 

Hardware/Software Requirement:

  1. Active internet connection (DSL or Cable). Dial-up connection will have constant buffering problems while viewing any media (audio/video).
  2. Compatible with Windows PC and MAC (256 MB of RAM or higher)
    • Windows OS 7.0 and higher.
    • MAC OS “Mountain Lion” and higher.
  3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 40.0 or higher with Adobe Flash content viewing capabilities.
  4. Peripherals: Speakers for audio.
  5. Adobe Reader to print certificate. Click here to download Adobe Reader for free.